INTRODUCTION
Pancreatic neuroendocrine tumors (NETs) are rare neoplasms that arise in the endocrine tissues of the pancreas and account for ＜3% of all primary pancreatic tumors. 1, 2 Most pancreatic NETs are sporadic, but may be associated with hereditary endocrinopathies. The reported annual incidence ranges between 0.32-0.43/100.000, but has risen recently due to increased detection of asymptomatic disease on cross-sectional imaging. 2, 3 The majority are non-functional and present with non-specific symptoms or are asymptomatic. Peptide hypersecretion from pancreatic NETs occasionally presents with a hormonal syndrome. [4] [5] [6] In general, they are associated with relatively good survival, although significant variability in outcomes may be seen, based on biological heterogeneity. [4] [5] [6] Functional status, tumor localization, histological grade and TNM classification are all important factors determining treatment strategy. Small (＜1-2 cm) locoregional, well-differentiated tumors with favourable imaging characteristics, have low metastatic potential and surgical resection alone usually offers excellent results.
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Conventional thermal ablative techniques such as radio-frequency ablation (RFA) and microwave ablation (MWA) can be used to treat pancreatic tumours, but there is a risk of thermal injury to the pancreatic duct and surrounding structures including the superior mesenteric artery (SMA), superior mesenteric vein (SMV), and duodenum.
Irreversible electroporation (IRE) is a novel non-thermal ablative therapy that is used primarily for treating liver tumors and pancreatic adenocarcinomas not amenable to resection or conventional ablation due to close proximity to major vascular or vital structures such as the bile duct or the pancreatic duct. 11 Its principle is based on the delivery of short-pulsed high-voltage electric current through electrodes positioned adjacent to the tumor causing irreversible injury to cell membrane and cell death by apoptosis. 11 For tumors located in the pancreas, it has been used for treatment of the non-metastatic locally ad- 
MATERIALS AND METHODS
Between April 2014 and March 2015, 3 patients underwent IRE for pancreatic neuroendocrine tumors ( Table 1) .
The first patient presented with frequent hypoglycaemic episodes, elevated serum insulin but normal C-peptide Following further discussion, IRE was offered.
RESULTS
The decision to proceed to treatment with IRE was made after multidisciplinary team discussion and patient choice and approval from the New and Novel Procedure Committee from our institution was obtained. IRE (Nanoknife system, Angiodynamics, Lanthan, NY, USA) was performed percutaneously with CT guidance under general anaesthesia. There were no adverse effects during the procedure. In the first two patients, 2 electrodes were used and in the 3 rd patient one additional electrode was required due to the size of tumor (Fig. 1B) . Delivery of 180 pulses at 2500-3000 watts was given to each patient.
Mean hospital stay was 2.6 days. The patient with insulinoma developed mild pancreatitis after procedure, which was treated conservatively. A further episode of pancreatitis was associated with a 13 cm-sized pseudocyst in the head of the pancreas. Despite the size of the cyst, the patient had limited symptoms and the fluid resolved without any intervention 4 months later ( Fig. 2A and 2B ).
No complications were reported for the other 2 patients.
Follow up at 12, 14 and 19 months with CT and MRI confirmed satisfactory ablation with no evidence of recurrence in all 3 patients (Fig. 1C and 1D) . with an excellent prognosis and depending on their location, enucleation rather than more radical surgery may suffice. 14, 15 Other studies have suggested that non-functional asymptomatic tumors ＜10 mm may be safely Improvements in ablative therapies continue and more data are required. 21, 22 Percutaneous and endoscopic RFA has also been used, but the thermal injury associated with this technique limits its use. 23, 24 IRE is a novel ablative technology that uses high-voltage electric pulses directed to tumor cells resulting in creation of nano-pores within the phospholipid bilayer of cell membrane, ultimately inducing apoptotic cell death. 20, 25, 26 It is considered superior to other ablative methods because little thermal energy is generated, underlying extracellular matrix is unaffected and adjacent vital structures such as vessels, nerves or ducts can be preserved. [25] [26] [27] The electrodes can be placed either percutaneously or during laparotomy/ laparoscopy. Absolute contraindications include cardiac arrhythmias or implanted pacemakers/defibrillators. 27, 28 The experience of IRE in the locally advanced, There is little available data on the use of this modality in the treatment of less aggressive pancreatic neoplasms such as NETs. This small pilot study shows that this form of locoregional therapy offers a novel approach to patients with small NETs of the pancreas or for surgically unfit patients with tumors ＜3 cm in diameter ( Table 2 ).
The three cases in our study had small, low grade tu- 
